Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal canc...
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)
About this item
Full title
Author / Creator
Kotaka, Masahito , Iwamoto, Shigeyoshi , Satake, Hironaga , Sakai, Daisuke , Kudo, Toshihiro , Fukunaga, Mutsumi , Konishi, Ken , Ide, Yoshihito , Ikumoto, Taro , Tsuji, Akihito , Sano, Yasushi , Kato, Takeshi , Sugimoto, Naotoshi , Satoh, Taroh , Kanazawa, Akiyoshi , Kurata, Takayasu , Yamanaka, Takeharu and Tomita, Naohiro
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
Background
Chemotherapy in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy is under debate. REACT study aimed to investigate the efficacy of reintroducing modified FOLFOX6 (mFOLFOX6) or CAPOX with or without bevacizumab in recurrent colorectal cancer patients after oxaliplatin adjuvant chemotherapy.
Metho...
Alternative Titles
Full title
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2404047486
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2404047486
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-020-01701-1
